InvestorsHub Logo
Followers 40
Posts 2492
Boards Moderated 0
Alias Born 04/07/2012

Re: casperboo post# 3336

Wednesday, 03/13/2013 5:29:16 PM

Wednesday, March 13, 2013 5:29:16 PM

Post# of 9289
You are absolutely correct. I listened to the entire conference call with interest. The company is solid and Lymphoseek is sold. The indication for melanoma and breast represents the majority of the market, and now that its approved, we can use it off label in other tumors as well.
Once Europe gets on board, we are looking over $7-8.
I went all in today on that huge dip.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NAVB News